Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Diabetes Care 36, 19331940.CrossRefGoogle ScholarPubMed Scott, RA, Freitag, DF, Li, L, Chu, AY, Surendran, P, Young, R, Grarup, N, Stanckov, A, Chen, Y, Varga, TV and Yaghootkar, H (2016) A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
Patients should be informed of potential side effects and safety-netted appropriately in case these occur
Administered as a once-weekly subcutaneous injection, it improves blood glucose control by stimulating insulin secretion, suppressing glucagon release, and slowing gastric emptying
Link Prescribing information (FDA/Novo Nordisk)
US$ 22.94
US$ 22.12
US$ 24.60
